Zhejiang Medicine Co Ltd (600216) — Cash Flow-to-Debt Ratio
Zhejiang Medicine Co Ltd (600216) has a Cash Flow-to-Debt Ratio of 0.24x as of September 2025, meaning its operating cash flow of CN¥690.77 Million could theoretically repay 0% of its total liabilities (CN¥2.92 Billion) in one year. Explore 600216 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Medicine Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Zhejiang Medicine Co Ltd across 28 annual periods. Also explore balance sheet size of Zhejiang Medicine Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Medicine Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Zhejiang Medicine Co Ltd. For market capitalisation and broader financial context, see how much is Zhejiang Medicine Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.63x | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +50.3% |
| 2024 | 0.42x | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +84.0% |
| 2023 | 0.23x | CN¥634.31 Million | CN¥2.79 Billion | ▲ +18.8% |
| 2022 | 0.19x | CN¥520.60 Million | CN¥2.72 Billion | ▼ -43.6% |
| 2021 | 0.34x | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -33.3% |
| 2020 | 0.51x | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +140.0% |
| 2019 | 0.21x | CN¥447.25 Million | CN¥2.11 Billion | ▼ -28.2% |
| 2018 | 0.30x | CN¥579.91 Million | CN¥1.96 Billion | ▲ +18.1% |
| 2017 | 0.25x | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.5% |
| 2016 | 0.18x | CN¥336.14 Million | CN¥1.82 Billion | ▲ +182.8% |
| 2015 | 0.07x | CN¥106.54 Million | CN¥1.63 Billion | ▼ -84.5% |
| 2014 | 0.42x | CN¥549.90 Million | CN¥1.31 Billion | ▼ -30.9% |
| 2013 | 0.61x | CN¥655.09 Million | CN¥1.08 Billion | ▼ -35.1% |
| 2012 | 0.94x | CN¥807.49 Million | CN¥860.73 Million | ▼ -17.9% |
| 2011 | 1.14x | CN¥912.75 Million | CN¥798.63 Million | ▼ -32.8% |
| 2010 | 1.70x | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.2% |
| 2009 | 1.44x | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +74.1% |
| 2008 | 0.83x | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +615.4% |
| 2007 | 0.12x | CN¥227.67 Million | CN¥1.97 Billion | ▲ +19.3% |
| 2006 | 0.10x | CN¥169.51 Million | CN¥1.75 Billion | ▲ +468.1% |
| 2005 | 0.02x | CN¥25.14 Million | CN¥1.48 Billion | ▼ -81.1% |
| 2004 | 0.09x | CN¥107.60 Million | CN¥1.19 Billion | ▲ +41.7% |
| 2003 | 0.06x | CN¥66.20 Million | CN¥1.04 Billion | ▲ +177.1% |
| 2002 | 0.02x | CN¥23.13 Million | CN¥1.01 Billion | ▼ -77.6% |
| 2001 | 0.10x | CN¥98.25 Million | CN¥956.66 Million | ▲ +677.9% |
| 2000 | 0.01x | CN¥10.58 Million | CN¥801.61 Million | ▲ +127.9% |
| 1999 | -0.05x | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -164.3% |
| 1998 | 0.07x | CN¥57.72 Million | CN¥782.87 Million | — |